These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 37231451)
1. METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma. Liu B; Cao J; Wu B; Hao K; Wang X; Chen X; Shen Z Cell Commun Signal; 2023 May; 21(1):121. PubMed ID: 37231451 [TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270 [TBL] [Abstract][Full Text] [Related]
3. Transcription factor RELA promotes hepatocellular carcinoma progression by promoting the transcription of m6A modulator METTL3. Wu J; Wang W; Zheng Y; Deng W; Liu J Pathol Res Pract; 2024 Mar; 255():155168. PubMed ID: 38367599 [TBL] [Abstract][Full Text] [Related]
4. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961 [TBL] [Abstract][Full Text] [Related]
5. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma. Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411 [No Abstract] [Full Text] [Related]
6. m Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312 [TBL] [Abstract][Full Text] [Related]
7. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2. Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970 [TBL] [Abstract][Full Text] [Related]
8. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
9. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α. Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825 [TBL] [Abstract][Full Text] [Related]
10. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway. Hu J; Chen K; Hong F; Gao G; Dai X; Yin H Cancer Gene Ther; 2024 Feb; 31(2):228-236. PubMed ID: 38030810 [TBL] [Abstract][Full Text] [Related]
11. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma. Guo S; Chen F; Li L; Dou S; Li Q; Huang Y; Li Z; Liu W; Zhang G J Adv Res; 2024 Jul; 61():165-178. PubMed ID: 37619934 [TBL] [Abstract][Full Text] [Related]
12. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881 [TBL] [Abstract][Full Text] [Related]
14. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner. Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546 [TBL] [Abstract][Full Text] [Related]
15. A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling. Sun S; Gao J; Zhou S; Li Y; Wang Y; Jin L; Li J; Liu B; Zhang B; Han S; Ding H; Li X J Exp Clin Cancer Res; 2020 Nov; 39(1):252. PubMed ID: 33222697 [TBL] [Abstract][Full Text] [Related]
16. METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway. Liu R; Yin G; Tuo H; Guo Y; Zhu Y; Zhang L; Yang W; Liu Q; Wang Y Biol Direct; 2023 Sep; 18(1):53. PubMed ID: 37658413 [TBL] [Abstract][Full Text] [Related]
17. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways. Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678 [TBL] [Abstract][Full Text] [Related]
18. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway. Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142 [TBL] [Abstract][Full Text] [Related]
19. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation. Ding H; Zhang X; Su Y; Jia C; Dai C Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532 [TBL] [Abstract][Full Text] [Related]
20. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis. Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]